Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease
Abstract
Publication Date:
2017
Iris type:
1.5 Abstract in rivista
List of contributors:
Fiorino, G; Ruiz-Aguello, Mb; Maguregui, A; Nagore, D; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, M; Martinez, A; Danese, S
Published in: